Detection Rate of 18F-Labeled PSMA PET/CT in Biochemical Recurrent Prostate Cancer: A Systematic Review and a Meta-Analysis
G Treglia, S Annunziata, DA Pizzuto, L Giovanella… - Cancers, 2019 - mdpi.com
Background: The use of radiolabeled prostate-specific membrane antigen positron emission
tomography/computed tomography (PSMA PET/CT) for biochemical recurrent prostate …
tomography/computed tomography (PSMA PET/CT) for biochemical recurrent prostate …
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head …
H Huo, S Shen, D He, B Liu, F Yang - Prostate Cancer and Prostatic …, 2023 - nature.com
Purpose Our meta-analysis aimed to evaluate the diagnostic performance of 68Ga-PSMA-
11 PET/CT vs. 68Ga-PSMA-11 PET/MRI for biochemical recurrence of prostate cancer …
11 PET/CT vs. 68Ga-PSMA-11 PET/MRI for biochemical recurrence of prostate cancer …
Diagnostic Accuracy of Multiparametric MRI versus 68Ga-PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in …
Background Recent studies have reported the additive value of combined gallium 68 (68Ga)-
labeled Glu-urea-Lys (Ahx)-HBED-CC ligand targeting the prostate-specific membrane …
labeled Glu-urea-Lys (Ahx)-HBED-CC ligand targeting the prostate-specific membrane …
[HTML][HTML] Radiolabelled choline versus PSMA PET/CT in prostate cancer restaging: a meta-analysis
G Treglia, RP Mestre, M Ferrari, DG Bosetti… - American journal of …, 2019 - ncbi.nlm.nih.gov
Both radiolabelled choline and prostate specific membrane antigen (PSMA) positron
emission tomography/computed tomography (PET/CT) could be used in patients with …
emission tomography/computed tomography (PET/CT) could be used in patients with …
Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer
DA Ferraro, HI Garcia Schüler, UJ Muehlematter… - European journal of …, 2020 - Springer
Background Accurate staging is of major importance to determine the optimal treatment
modality for patients with prostate cancer. Positron emission tomography (PET) with prostate …
modality for patients with prostate cancer. Positron emission tomography (PET) with prostate …
[HTML][HTML] Metastatic sites' Location and impact on patient management after the introduction of prostate-specific membrane antigen positron emission tomography in …
Context The introduction of prostate-specific membrane antigen positron emission
tomography (PSMA-PET) had a substantial impact on the management of prostate cancer …
tomography (PSMA-PET) had a substantial impact on the management of prostate cancer …
Comparison of 3 interpretation criteria for 68Ga-PSMA11 PET based on inter-and intrareader agreement
A Toriihara, T Nobashi, L Baratto, H Duan… - Journal of Nuclear …, 2020 - Soc Nuclear Med
PET using radiolabeled prostate-specific membrane antigen (PSMA) is now being more
widely adopted as a valuable tool to evaluate patients with prostate cancer (PC). Recently, 3 …
widely adopted as a valuable tool to evaluate patients with prostate cancer (PC). Recently, 3 …
Clinical impact of 68Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its …
J Müller, DA Ferraro, UJ Muehlematter… - European journal of …, 2019 - Springer
Purpose The fast-increasing use of positron emission tomography (PET) with prostate-
specific membrane antigen (PSMA) ligand for the imaging of prostate cancer (PCA) …
specific membrane antigen (PSMA) ligand for the imaging of prostate cancer (PCA) …
Robotic-assisted surgery for the treatment of urologic cancers: recent advances
U Falagario, A Veccia, S Weprin… - Expert Review of …, 2020 - Taylor & Francis
Introduction As the medical field is moving toward personalized and tailored approaches, we
entered the era of precision surgery for the management of genitourinary cancers1. This is …
entered the era of precision surgery for the management of genitourinary cancers1. This is …
Correlation between PSA kinetics and PSMA‐PET in prostate cancer restaging: a meta‐analysis
R Pereira Mestre, G Treglia, M Ferrari… - European journal of …, 2019 - Wiley Online Library
Background Serum prostate‐specific antigen (PSA) may predict the risk of positive positron
emission tomography/computed tomography with radiolabelled prostate‐specific membrane …
emission tomography/computed tomography with radiolabelled prostate‐specific membrane …